Maximus Inc. (NYSE:MMS) CEO Richard A. Montoni sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, November 25th. The stock was sold at an average price of $57.00, for a total value of $1,425,000.00. Following the transaction, the chief executive officer now directly owns 641,114 shares in the company, valued at $36,543,498. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Shares of Maximus Inc. (NYSE:MMS) opened at 57.33 on Friday. The stock has a market capitalization of $3.77 billion, a price-to-earnings ratio of 21.31 and a beta of 1.15. The stock’s 50 day moving average price is $53.77 and its 200 day moving average price is $56.30. Maximus Inc. has a 12 month low of $43.69 and a 12 month high of $61.68.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, November 10th. The company reported $0.77 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.72 by $0.05. Maximus had a return on equity of 24.93% and a net margin of 7.42%. The company had revenue of $623.10 million for the quarter, compared to analyst estimates of $610.65 million. During the same period in the previous year, the company posted $0.53 earnings per share. The firm’s revenue was up 7.7% on a year-over-year basis. Analysts expect that Maximus Inc. will post $3.00 EPS for the current year.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 30th. Investors of record on Tuesday, November 15th will be given a dividend of $0.045 per share. The ex-dividend date of this dividend is Thursday, November 10th. This represents a $0.18 annualized dividend and a dividend yield of 0.31%. Maximus’s dividend payout ratio is presently 6.67%.

ILLEGAL ACTIVITY WARNING: This story was first published by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark laws. The correct version of this story can be viewed at https://www.thecerbatgem.com/2016/11/26/maximus-inc-mms-ceo-sells-1425000-00-in-stock-2.html.

Several large investors have recently added to or reduced their stakes in the stock. D.A. Davidson & CO. raised its stake in Maximus by 4.6% in the third quarter. D.A. Davidson & CO. now owns 79,470 shares of the company’s stock valued at $4,491,000 after buying an additional 3,463 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in Maximus by 3.2% in the third quarter. Price T Rowe Associates Inc. MD now owns 759,798 shares of the company’s stock valued at $42,974,000 after buying an additional 23,698 shares in the last quarter. Sawtooth Solutions LLC raised its stake in Maximus by 14.0% in the third quarter. Sawtooth Solutions LLC now owns 6,246 shares of the company’s stock valued at $353,000 after buying an additional 766 shares in the last quarter. Credit Suisse AG raised its stake in Maximus by 0.8% in the third quarter. Credit Suisse AG now owns 187,719 shares of the company’s stock valued at $10,618,000 after buying an additional 1,417 shares in the last quarter. Finally, Ameritas Investment Partners Inc. raised its stake in Maximus by 65.2% in the third quarter. Ameritas Investment Partners Inc. now owns 25,346 shares of the company’s stock valued at $1,434,000 after buying an additional 10,000 shares in the last quarter. Institutional investors own 99.72% of the company’s stock.

A number of brokerages have recently weighed in on MMS. Zacks Investment Research lowered Maximus from a “hold” rating to a “sell” rating in a research report on Saturday, November 12th. Jefferies Group reissued a “buy” rating and issued a $65.00 price target (down from $67.00) on shares of Maximus in a research report on Wednesday, November 16th. Maxim Group increased their price target on Maximus from $71.00 to $74.00 and gave the company a “buy” rating in a research report on Thursday, August 4th. Sidoti lowered Maximus from a “buy” rating to a “neutral” rating and set a $55.00 price target for the company. in a research report on Tuesday, November 15th. Finally, Raymond James Financial Inc. lowered Maximus from an “outperform” rating to a “market perform” rating in a research report on Wednesday, November 9th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $61.89.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.

5 Day Chart for NYSE:MMS

Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.